{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:24:01Z","timestamp":1794273841530,"version":"4.9.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Centro Servizi ANMCO SrL - Societ\u00e0 Benefit"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypertrophic cardiomyopathy (HCM) is a non-rare genetic cardiomyopathy, with an estimated prevalence of 1:500, characterized by an increase in the left ventricular wall thickness in the absence of increased loading conditions. The hypertrophy is mostly asymmetric and predominantly affects the basal septum and anterior wall. Left ventricular outflow tract obstruction, at rest or after provocative tests, is detected in many patients and represents the primary cause of reduced functional capacity, as well as an independent predictor of sudden cardiac death and advanced heart failure. Until \u223c1 year ago, symptomatic patients despite maximal therapy with \u03b2-blockers or calcium channel blockers plus disopyramide had only basal septal reduction therapy through myectomy or septal alcoholization as additional therapeutic options. Today, a new class of drugs that inhibit cardiac myosin activity is available for patients with obstructive HCM. In light of the new treatment perspectives, the correct clinical-therapeutic classification of affected patients becomes of fundamental importance for the cardiologist. The aim of this position paper is to increase the knowledge of cardiologists in the field of HCM, defining its epidemiological, genetic, and pathological characteristics, identifying the diagnostic criteria and instrumental methods capable of stratifying the risk profile, with the aim of an optimal therapy tailored on the single patient.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suaf077","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:55:05Z","timestamp":1741334105000},"page":"v256-v279","source":"Crossref","is-referenced-by-count":7,"title":["ANMCO position paper \u2018Hypertrophic cardiomyopathy: from diagnosis to treatment\u2019"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-3796","authenticated-orcid":false,"given":"Cristina","family":"Chimenti","sequence":"first","affiliation":[{"name":"UOC Malattie Apparato Cardiovascolare, AOU \u2018Policlinico Umberto I\u2019, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Universit\u00e0 di Roma , Viale del Policlinico, 155, Roma 00161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0347-6672","authenticated-orcid":false,"given":"Attilio","family":"Iacovoni","sequence":"additional","affiliation":[{"name":"UOC Cardiologia 1, ASST Papa Giovanni XXIII , Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Montalto","sequence":"additional","affiliation":[{"name":"UOC Cardiochirurgia, Azienda Ospedaliera Sant\u2019Anna e San Sebastiano , Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-1962","authenticated-orcid":false,"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[{"name":"Cardiologia e Medicina Cardiovascolare, Fondazione Toscana Gabriele Monasterio (FTGM)\u2014Stabilimento di Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-9266","authenticated-orcid":false,"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[{"name":"SOC Cardiologia Pediatrica e della Transizione, AOU Meyer\u2014IRCCS , Firenze ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-9753","authenticated-orcid":false,"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[{"name":"UOC Patologia Cardiovascolare, Azienda Ospedaliera- Dipartimento di Scienze Cardio-toraco-vascolari e di Sanit\u00e0 Pubblica, Universit\u00e0 degli Studi , Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8383-4227","authenticated-orcid":false,"given":"Benedetta Carla","family":"De Chiara","sequence":"additional","affiliation":[{"name":"SC Cardiochirurgia e del Trapianto di Cuore, ASST Grande Ospedale Metropolitano Niguarda , Milano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bottillo","sequence":"additional","affiliation":[{"name":"UOC Laboratorio di Genetica Medica, Dipartimento di Medicina Sperimentale, A.O. San Camillo Forlanini , Roma ,","place":["Italy"]},{"name":"Sapienza Universit\u00e0 , Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-8464","authenticated-orcid":false,"given":"Claudio Mario","family":"Ciampi","sequence":"additional","affiliation":[{"name":"UOC Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione \u2018Garibaldi\u2019 , Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-4040","authenticated-orcid":false,"given":"Santo","family":"Dellegrottaglie","sequence":"additional","affiliation":[{"name":"Laboratorio RM Cardiovascolare\u2014Unit\u00e0 Imaging Cardiovascolare Avanzato, Ospedale Medico-Chirurgico Accreditato Villa dei Fiori , Acerra, NA, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4423-5202","authenticated-orcid":false,"given":"Massimo","family":"Di Marco","sequence":"additional","affiliation":[{"name":"UOC Cardiologia-UTIC, Ospedale Santo Spirito , Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-3548","authenticated-orcid":false,"given":"Piero","family":"Gentile","sequence":"additional","affiliation":[{"name":"Cardiologia 2\u2014Insufficienza Cardiaca e Trapianto, Dipartimento Cardiotoracovascolare \u2018A. De Gasperis\u2019, ASST Grande Ospedale Metropolitano Niguarda , Milano, Italy"},{"name":"Scuola di Medicina e Chirurgia, Universit\u00e0 Bicocca , Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3597","authenticated-orcid":false,"given":"Francesca","family":"Girolami","sequence":"additional","affiliation":[{"name":"SOC Cardiologia Pediatrica e della Transizione, AOU Meyer\u2014IRCCS , Firenze ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Grammatico","sequence":"additional","affiliation":[{"name":"UOC Laboratorio di Genetica Medica, Dipartimento di Medicina Sperimentale, A.O. San Camillo Forlanini , Roma ,","place":["Italy"]},{"name":"Sapienza Universit\u00e0 , Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-212X","authenticated-orcid":false,"given":"Maria","family":"Iascone","sequence":"additional","affiliation":[{"name":"Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII , Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-8577","authenticated-orcid":false,"given":"Eluisa","family":"La Franca","sequence":"additional","affiliation":[{"name":"Dipartimento di Cardiologia, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)-IRCCS, UPMC , Palermo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4683-7807","authenticated-orcid":false,"given":"Carla","family":"Lofiego","sequence":"additional","affiliation":[{"name":"SOD Cardiologia-UTIC, Dipartimento di Scienze Cardiovascolari, AOU delle Marche , Ancona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-6178","authenticated-orcid":false,"given":"Andrea","family":"Matteucci","sequence":"additional","affiliation":[{"name":"UOC Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri\u2014ASL Roma 1 , Roma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-2786","authenticated-orcid":false,"given":"Daniele","family":"Pasqualucci","sequence":"additional","affiliation":[{"name":"Cardiologia con UTIC, Azienda Ospedaliera \u2018G. Brotzu\u2019 , Cagliari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Pentiricci","sequence":"additional","affiliation":[{"name":"Cardiochirurgia, ASST Papa Giovanni XXIII , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Perugini","sequence":"additional","affiliation":[{"name":"UOC Cardiologia, Ospedale Maggiore , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-4292","authenticated-orcid":false,"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[{"name":"Cardiomiopatie, AOU Careggi\u2014Universit\u00e0 degli Studi , Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Quarta","sequence":"additional","affiliation":[{"name":"UOC Cardiologia 1, ASST Papa Giovanni XXIII , Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Re","sequence":"additional","affiliation":[{"name":"UOC Cardiologia, Dipartimento di Scienze Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini , Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9409-691X","authenticated-orcid":false,"given":"Laura","family":"Scelsi","sequence":"additional","affiliation":[{"name":"SC Cardiologia, Dipartimento Cardio-Toraco-Vascolare, Fondazione IRCCS Policlinico San Matteo , Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[{"name":"Cardiologia e Medicina Cardiovascolare, Fondazione Toscana Gabriele Monasterio (FTGM)\u2014Stabilimento di Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-4262","authenticated-orcid":false,"given":"Maria","family":"Alfarano","sequence":"additional","affiliation":[{"name":"UOC Malattie Apparato Cardiovascolare, AOU \u2018Policlinico Umberto I\u2019, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Universit\u00e0 di Roma , Viale del Policlinico, 155, Roma 00161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Gaspari","sequence":"additional","affiliation":[{"name":"UOC Patologia Cardiovascolare, Azienda Ospedaliera- Dipartimento di Scienze Cardio-toraco-vascolari e di Sanit\u00e0 Pubblica, Universit\u00e0 degli Studi , Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-0579","authenticated-orcid":false,"given":"Claudio","family":"Bilato","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia, Ospedali dell\u2019Ovest Vicentino, Azienda ULSS 8 Berica , Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Corda","sequence":"additional","affiliation":[{"name":"Cardiologia con UTIC, Azienda Ospedaliera \u2018G. Brotzu\u2019 , Cagliari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-1272","authenticated-orcid":false,"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[{"name":"SC Cardiologia, Dipartimento Cardio-Toraco-Vascolare, Fondazione IRCCS Policlinico San Matteo , Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-8717","authenticated-orcid":false,"given":"Giovanna","family":"Geraci","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia, Presidio Ospedaliero Sant\u2019Antonio Abate, ASP Trapani , Erice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-6224","authenticated-orcid":false,"given":"Massimo","family":"Milli","sequence":"additional","affiliation":[{"name":"Cardiologia Firenze 1 (Ospedali S. Maria Nuova e Nuovo San Giovanni di Dio), Azienda USL Toscana Centro , Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8417-7783","authenticated-orcid":false,"given":"Alessandro","family":"Navazio","sequence":"additional","affiliation":[{"name":"S.O.C. Cardiologia Ospedaliera, Presidio Ospedaliero Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia\u2014IRCCS , ReggioEmilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-4709","authenticated-orcid":false,"given":"Vittorio","family":"Pascale","sequence":"additional","affiliation":[{"name":"UTIC-Emodinamica e Cardiologia Interventistica, Ospedale Civile Pugliese , Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0160-3674","authenticated-orcid":false,"given":"Carmine","family":"Riccio","sequence":"additional","affiliation":[{"name":"U.O.S.D. Follow-up del Paziente Post-Acuto, Dipartimento Cardio-Vascolare, AORN Sant\u2019Anna e San Sebastiano , Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scicchitano","sequence":"additional","affiliation":[{"name":"U.O. Cardiologia-UTIC, Ospedale \u2018F. Perinei\u2019 , Altamura BA, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Tizzani","sequence":"additional","affiliation":[{"name":"Dipartimento di Cardiologia, Ospedale degli Infermi , Rivoli, TO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-7125","authenticated-orcid":false,"given":"Michele Massimo","family":"Gulizia","sequence":"additional","affiliation":[{"name":"UOC Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione \u2018Garibaldi\u2019 , Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7743-2587","authenticated-orcid":false,"given":"Federico","family":"Nardi","sequence":"additional","affiliation":[{"name":"Dipartimento di Cardiologia, Ospedale Santo Spirito , Casale Monferrato AL, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-0527","authenticated-orcid":false,"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"UOC Cardiologia, Dipartimento di Scienze Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini , Roma, Italy"},{"name":"Fondazione per il Tuo cuore\u2014Heart Care Foundation , Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-2234","authenticated-orcid":false,"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[{"name":"UOC Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri\u2014ASL Roma 1 , Roma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-8884","authenticated-orcid":false,"given":"Massimo","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia-UTIC, Ospedale Miulli , Acquaviva delle Fonti, BA, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-996X","authenticated-orcid":false,"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[{"name":"Fondazione per il Tuo cuore\u2014Heart Care Foundation , Firenze, Italy"},{"name":"U.O.C. Cardiologia-UTIC, Ospedale Miulli , Acquaviva delle Fonti, BA, Italy"},{"name":"Cardiologia 1-Emodinamica, Dipartimento Cardiotoracovascolare \u2018A. De Gasperis\u2019, ASST Grande Ospedale Metropolitano Niguarda , Milano, Italy"},{"name":"Associazione Nazionale Medici Cardiologi Ospedalieri\u2014ANMCO , Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"2025091923145145300_suaf077-B1","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B2","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B3","first-page":"185","article-title":"Update sulla gestione del paziente con cardiomiopatia ipertrofica alla luce delle nuove linee guida nord-americane","volume":"26","author":"Bertero","year":"2025","journal-title":"G Ital Cardiol (Rome)"},{"key":"2025091923145145300_suaf077-B4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025091923145145300_suaf077-B5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025091923145145300_suaf077-B7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pcad.2023.08.002","article-title":"The evolving paradigm and current perception of hypertrophic cardiomyopathy: implications for management","volume":"80","author":"Del Franco","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"2025091923145145300_suaf077-B8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"19","author":"Wilde","year":"2022","journal-title":"Heart Rhythm"},{"key":"2025091923145145300_suaf077-B10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41431-023-01421-w","article-title":"EMQN: recommendations for genetic testing in inherited cardiomyopathies and arrhythmias","volume":"31","author":"Hayesmoore","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"2025091923145145300_suaf077-B11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2025091923145145300_suaf077-B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00428-021-03038-0","article-title":"Cardiac hypertrophy at autopsy","volume":"479","author":"Basso","year":"2021","journal-title":"Virchows Arch"},{"key":"2025091923145145300_suaf077-B13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.CIR.59.4.689","article-title":"Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy","volume":"59","author":"Maron","year":"1979","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"2025091923145145300_suaf077-B16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025091923145145300_suaf077-B17","doi-asserted-by":"crossref","first-page":"100337","DOI":"10.1016\/j.jacadv.2023.100337","article-title":"Lifetime clinical course of hypertrophic cardiomyopathy: outcome of the historical florence cohort over 5 decades","volume":"2","author":"Maurizi","year":"2023","journal-title":"JACC Adv"},{"key":"2025091923145145300_suaf077-B18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10554-022-02774-x","article-title":"Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360\u00b0 panorama","volume":"39","author":"Aguiar Rosa","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025091923145145300_suaf077-B20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10741-023-10358-7","article-title":"Electrocardiographic abnormalities in patients with cardiomyopathies","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev"},{"key":"2025091923145145300_suaf077-B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/heartjnl-2020-318271","article-title":"Standard ECG for differential diagnosis between Anderson\u2013Fabry disease and hypertrophic cardiomyopathy","volume":"108","author":"Vitale","year":"2022","journal-title":"Heart"},{"key":"2025091923145145300_suaf077-B22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.hrthm.2019.07.019","article-title":"The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy","volume":"17","author":"Finocchiaro","year":"2020","journal-title":"Heart Rhythm"},{"key":"2025091923145145300_suaf077-B23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2025091923145145300_suaf077-B24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","article-title":"Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography","volume":"35","author":"Nagueh","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923145145300_suaf077-B25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.echo.2023.04.020","article-title":"A practical approach to echocardiographic imaging in patients with hypertrophic cardiomyopathy","volume":"36","author":"Mitchell","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923145145300_suaf077-B26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/00015385.2017.1291155","article-title":"Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy","volume":"9","author":"Bayrak","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2025091923145145300_suaf077-B28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","article-title":"Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity","volume":"18","author":"Yang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923145145300_suaf077-B29","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025091923145145300_suaf077-B30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"2025091923145145300_suaf077-B31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.echo.2024.06.011","article-title":"Unmasking obstruction in hypertrophic cardiomyopathy with postprandial resting and treadmill stress echocardiography","volume":"37","author":"Massera","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923145145300_suaf077-B32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.echo.2024.05.009","article-title":"On the cause of systolic anterior motion in obstructive hypertrophic cardiomyopathy","volume":"37","author":"Sherrid","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923145145300_suaf077-B33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/diagnostics12020314","article-title":"The role of cardiovascular magnetic resonance imaging in the evaluation of hypertrophic cardiomyopathy","volume":"12","author":"Sivalokanathan","year":"2022","journal-title":"Diagnostics"},{"key":"2025091923145145300_suaf077-B34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2023.07.012","article-title":"Improved diagnostic criteria for apical hypertrophic cardiomyopathy","volume":"17","author":"Hughes","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025091923145145300_suaf077-B35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025091923145145300_suaf077-B37","doi-asserted-by":"crossref","first-page":"e010489","DOI":"10.1161\/CIRCIMAGING.120.010489","article-title":"Late gadolinium enhancement-dispersion mapping: a new magnetic resonance imaging technique to assess prognosis in patients with hypertrophic cardiomyopathy and low-intermediate 5-year risk of sudden death","volume":"13","author":"Aquaro","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025091923145145300_suaf077-B38","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.07.015","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"250","author":"Dejgaard","year":"2018","journal-title":"Int J Cardiol"},{"key":"2025091923145145300_suaf077-B40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025091923145145300_suaf077-B41","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025091923145145300_suaf077-B42","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/ejhf.3076","article-title":"Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies","volume":"25","author":"Polovina","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025091923145145300_suaf077-B43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.124.069378","article-title":"Long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy: insights from the SHARE registry","volume":"150","author":"Maurizi","year":"2024","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B44","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2014.07.075","article-title":"Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from nationwide inpatient sample [1998\u20132010])","volume":"114","author":"Panaich","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025091923145145300_suaf077-B45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21037\/acs.2017.06.04","article-title":"Current state of the art and future of myectomy","volume":"6","author":"Yacoub","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2025091923145145300_suaf077-B46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","article-title":"Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"74","author":"Cui","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025091923145145300_suaf077-B47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12055-019-00817-y","article-title":"Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy","volume":"36","author":"Hong","year":"2020","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"2025091923145145300_suaf077-B48","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025091923145145300_suaf077-B49","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025091923145145300_suaf077-B50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025091923145145300_suaf077-B51","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","article-title":"Electrophysiological and contractile effects of disopyramide in patients with obstructive hypertrophic cardiomyopathy: a translational study","volume":"4","author":"Coppini","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2025091923145145300_suaf077-B53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ejhf.3120","article-title":"Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population","volume":"26","author":"Bertero","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025091923145145300_suaf077-B54","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41591-021-01505-4","article-title":"Valsartan in early-stage hypertrophic cardiomyopathy: a randomized Phase 2 trial","volume":"27","author":"Ho","year":"2021","journal-title":"Nat Med"},{"key":"2025091923145145300_suaf077-B55","doi-asserted-by":"crossref","first-page":"e011663","DOI":"10.1161\/CIRCHEARTFAILURE.124.011663","article-title":"Quality of life and exercise capacity in early stage and subclinical hypertrophic cardiomyopathy: a secondary analysis of the VANISH trial","volume":"17","author":"Ireland","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2025091923145145300_suaf077-B56","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ejhf.3291","article-title":"Sacubitril\/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: an open label randomized controlled trial (SILICOFCM)","volume":"26","author":"Velicki","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025091923145145300_suaf077-B57","doi-asserted-by":"crossref","first-page":"100843","DOI":"10.1016\/j.jacadv.2024.100843","article-title":"Impact of sodium-glucose cotransporter 2 inhibitors on mortality in hypertrophic cardiomyopathy","volume":"3","author":"Aglan","year":"2024","journal-title":"JACC Adv"},{"key":"2025091923145145300_suaf077-B58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","article-title":"Targeting the sarcomere in inherited cardiomyopathies","volume":"19","author":"Lehman","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2025091923145145300_suaf077-B59","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1093\/eurheartj\/ehad637","article-title":"Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy","volume":"44","author":"Braunwald","year":"2023","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, Phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2025091923145145300_suaf077-B61","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"2025091923145145300_suaf077-B62","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Desnick","year":"2001"},{"key":"2025091923145145300_suaf077-B63","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","article-title":"Anderson\u2013Fabry disease management: role of the cardiologist","volume":"45","author":"Pieroni","year":"2024","journal-title":"Eur Heart J"},{"key":"2025091923145145300_suaf077-B64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"2025091923145145300_suaf077-B65","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025091923145145300_suaf077-B66","doi-asserted-by":"crossref","first-page":"e032734","DOI":"10.1161\/JAHA.123.032734","article-title":"Long-term clinical-pathologic results of enzyme replacement therapy in prehypertrophic fabry disease cardiomyopathy","volume":"13","author":"Frustaci","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2025091923145145300_suaf077-B67","doi-asserted-by":"crossref","first-page":"e009052","DOI":"10.1161\/JAHA.118.009052","article-title":"Immune-mediated myocarditis in Fabry disease cardiomyopathy","volume":"7","author":"Frustaci","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025091923145145300_suaf077-B68","doi-asserted-by":"crossref","first-page":"1395287","DOI":"10.3389\/fgene.2024.1395287","article-title":"Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease","volume":"15","author":"Germain","year":"2024","journal-title":"Front Genet"},{"key":"2025091923145145300_suaf077-B69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/978-3-031-51757-0","volume-title":"Cardiac Amyloidosis: Diagnosis and Treatment","author":"Emdin","year":"2024"},{"key":"2025091923145145300_suaf077-B70","first-page":"900","article-title":"Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca\u2014documento di consenso SIC\/ANMCO. A cura della Rete Italiana dell\u2019Amiloidosi Cardiaca (RIAC) [diagnostic\u2013therapeutic care pathways for patients with cardiac amyloidosis\u2014SIC\/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]","volume":"25","author":"Porcari","year":"2024","journal-title":"G Ital Cardiol (Rome)"},{"key":"2025091923145145300_suaf077-B71","first-page":"S1936-878X(24)00458-3","article-title":"The last decade in cardiac amyloidosis: advances in understanding pathophysiology, diagnosis and quantification, prognosis, treatment strategies, and monitoring response","author":"Fontana","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025091923145145300_suaf077-B72","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2025091923145145300_suaf077-B73","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic light chain amyloidosis","volume":"390","author":"Sanchorawala","year":"2024","journal-title":"N Engl J Med"},{"key":"2025091923145145300_suaf077-B74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"2025091923145145300_suaf077-B75","article-title":"Cardiomiopatia ipertrofica dalla diagnosi al trattamento","author":"Chimenti","year":"2025","journal-title":"G Ital Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/27\/Supplement_5\/v256\/63182993\/suaf077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/27\/Supplement_5\/v256\/63182993\/suaf077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T03:18:19Z","timestamp":1758338299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/27\/Supplement_5\/v256\/8131722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":75,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2025,5,15]]},"published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf077","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,5]]}}}